Randomized, double-blind, placebo-controlled crossover trial of pirenzepine in patients with gastroesophageal reflux
- 1 February 1992
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 37 (2) , 297-302
- https://doi.org/10.1007/bf01308187
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- Effects of antireflux therapies on salivary function in normal humansDigestive Diseases and Sciences, 1987
- Ambulatory 24-Hour Esophageal pH MonitoringJournal of Clinical Gastroenterology, 1986
- Oral pirenzepine does not affect esophageal pressures in manDigestive Diseases and Sciences, 1986
- Pirenzepine in the Treatment of Reflux Oesophagitis: A Placebo-Controlled, Double-Blind StudyScandinavian Journal of Gastroenterology, 1986
- Pirenzepine A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in Peptic Ulcer Disease and Other Allied DiseasesDrugs, 1985
- Effect of Esophageal Emptying and Saliva on Clearance of Acid from the EsophagusNew England Journal of Medicine, 1984
- Effect of Pirenzepine Compared with Atropine and L-Hyoscyamine on Esophageal Peristaltic Activity in HumansScandinavian Journal of Gastroenterology, 1982
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Estimation of the Box Correction for Degrees of Freedom from Sample Data in Randomized Block and Split-Plot DesignsJournal of Educational Statistics, 1976